OTCMKTS:MDRSF Medartis (MDRSF) Stock Price, News & Analysis C$102.01 0.00 (0.00%) As of 08/22/2025 Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartShort InterestBuy This Stock About Medartis Stock (OTCMKTS:MDRSF) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Medartis alerts:Sign Up Key Stats Today's RangeC$102.01▼C$102.0150-Day RangeC$51.70▼C$102.0152-Week RangeC$51.50▼C$102.01VolumeN/AAverage Volume300 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingHold Company Overview Medartis Holding AG, a medical device company, develops, manufactures, and sells implant solutions worldwide. Its medical devices are used for the treatment of surgical fixation of bone fractures for upper and lower extremities, as well as for the cranio-maxillofacial surgery. The company offers osteosynthesis instruments for the areas of the hand, wrist, forearm, elbow, shoulder, and foot and ankle, as well as for the areas of the mandible, midface, orthognathic, and cranium under the APTUS and MODUS names. It serves the surgeons, hospitals, and medical centers, as well as group purchasing organizations. The company was founded in 1997 and is headquartered in Basel, Switzerland. Read More Receive MDRSF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Medartis and its competitors with MarketBeat's FREE daily newsletter. Email Address MDRSF Stock News HeadlinesMedartis Holding AG (XSWX:MED) (Q2 2025) Earnings Call Highlights: Strong Revenue Growth and ...August 20, 2025 | gurufocus.comMedartis to Present 2025 Half-Year Results via WebcastJuly 30, 2025 | tipranks.comTax Drain Deadline: Protect Your Wealth Before September 15thOn September 15th, the IRS collects another round of quarterly tax payments—targeting self-employed professionals, retirees, and high-net-worth savers. But the wealthy aren’t just writing checks. They’re moving fast to protect capital and purchasing power using legal, IRS-compliant strategies. American Alternative Assets just released the Mar-A-Lago Accord, a free guide revealing how to reduce Q3 tax exposure and reposition wealth before it’s drained.August 24 at 2:00 AM | American Alternative (Ad)Medartis delivers 12% core sales growth in 2024 and improves its core EBITDA margin from 17% to 19%March 19, 2025 | markets.businessinsider.comMedartis Holding AG (XSWX:MED) (Q4 2024) Earnings Call Highlights: Strong Revenue Growth and ...March 19, 2025 | gurufocus.comHalf Year 2024 Medartis Holding AG Earnings Call TranscriptAugust 21, 2024 | gurufocus.comMedartis Holding AG (MDRSF) (Q2 2024) Earnings Call Transcript Highlights: Strong Revenue ...August 21, 2024 | gurufocus.comSynektik SA (A2P.SG)August 3, 2024 | finance.yahoo.comSee More Headlines MDRSF Stock Analysis - Frequently Asked Questions How have MDRSF shares performed this year? Medartis' stock was trading at C$51.70 on January 1st, 2025. Since then, MDRSF stock has increased by 97.3% and is now trading at C$102.01. How do I buy shares of Medartis? Shares of MDRSF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Industry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Medical Devices Sub-IndustryN/A Current SymbolOTCMKTS:MDRSF CIKN/A Webwww.medartis.com Phone41 61 633 34 34FaxN/AEmployees860Year FoundedN/AProfitability EPS (Trailing Twelve Months)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A A Guide To High-Short-Interest StocksMarketBeat's analysts have just released their top five short plays for September 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.Get This Free Report This page (OTCMKTS:MDRSF) was last updated on 8/24/2025 by MarketBeat.com Staff From Our PartnersEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredTrump’s betrayal exposedTrump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredA New Way to Double Your Retirement Income?Bloomberg reports that a new class of investments is “entering a golden era,” with yields fueling a retail boo...Investors Alley | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredOne tiny company just cracked Google’s $19B problemAn MIT lab recently cracked a code scientists had been chasing for decades… Turning a “miracle metal” from ...True Market Insiders | SponsoredIs This Stock the 'Next Nvidia'?'AI Bottleneck' Now Threatens Entire Magnificent 7 A new critical failure has appeared in the AI market, an...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Medartis Holding AG Please log in to your account or sign up in order to add this asset to your watchlist. Share Medartis With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.